ArriVent BioPharma (AVBP) Interest & Investment Income (2023 - 2026)
ArriVent BioPharma (AVBP) posted Interest & Investment Income of $2.8 million for Q2 2026, up 25.8% from $2.22 million a year earlier and up 0.3% from the prior quarter.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Interest & Investment Income (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at ArriVent BioPharma was $12.21 million, up 7.6% year-over-year; for FY2025, it came in at $11.23 million, down 18.8% from FY2024.
- In prior years, ArriVent BioPharma's Interest & Investment Income was $13.82 million in FY2024 (+162.9%) and $5.26 million in FY2023.
- Quarterly Interest & Investment Income has run from a low of $1.02 million in Q2 2023 to a high of $3.82 million in Q2 2024 over five years.
- On a year-over-year basis, Interest & Investment Income has increased in each of the last three quarters, with growth averaging 11.3% over the last eight quarters.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2024, with growth of 275.9%; the weakest was Q2 2025, with a decline of 41.8%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $2.79 million (Q1 2026), $3.28 million (Q4 2025) and $3.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | ArriVent BioPharma | 1.37 Bn | 1.37 Bn | - | 2.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.80 Mn |
| Mar 31, 2026 | 2.79 Mn |
| Dec 31, 2025 | 3.28 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 2.22 Mn |
| Mar 31, 2025 | 2.39 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Sep 30, 2024 | 3.67 Mn |
| Jun 30, 2024 | 3.82 Mn |
| Mar 31, 2024 | 3.26 Mn |
| Dec 31, 2023 | 1.93 Mn |
| Sep 30, 2023 | 2.32 Mn |
| Jun 30, 2023 | 1.02 Mn |
API Access
ArriVent BioPharma Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();